Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-11-15T04:34:28.011Z Has data issue: false hasContentIssue false
  • English
  • Français

Dealing with Discounting: An Application to the Cost-Effectiveness of Intracoronary Thrombolysis with Streptokinase

Published online by Cambridge University Press:  10 March 2009

Léon Martens  and
Eddy Van Doorslaer
Léon Martens
Affiliation:
Erasmus University
Eddy Van Doorslaer
Affiliation:
University of Limburg
Get access Rights & Permissions [Opens in a new window]

Extract

By introducing discounting in the DEALE method, we reanalyze a recent publication on the cost-effectiveness of early thrombolytic therapy with intracoronary streptokinase after acute myocardial infarction. We show that failure to discount gains in life expectancy results in a serious overestimation of the cost-effectiveness of this technology.

Type
General Essays
Information
International Journal of Technology Assessment in Health Care , Volume 6 , Issue 1 , January 1990 , pp. 139 - 145
Copyright
Copyright © Cambridge University Press 1990

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Beck, J. R., Kassire, J. P., & Pauker, S. G.A convenient approximation of life expectancy; The “DEALE.” American Journal of Medicine, 1982, 73, 863–97.Google Scholar
Chiang, A. C.Fundamental methods of mathematical economics. Tokyo: McGraw-Hill, 1974.Google Scholar
Culyer, A. J. Technology assessment in Europe: Its present and future roles. En Rutten, F. F. H. & Reiser, S. J. (eds.), The economics of medical technology. Heidelberg: Springer, 1988, 54–79.CrossRefGoogle Scholar
Drummond, M. F., Stoddart, G. L., & Torrance, G. W.Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press, 1987.Google Scholar
Fuchs, V., & Zeckhauser, R.Valuing health, a “priceless” commodity. American Economic Review, 1987, 77, 263–68.Google Scholar
Guyatt, G., Drummond, M., Feeney, D. et al. , Guidelines for the clinical and economic evaluation of health care technologies. Social Science and Medicine, 1986, 22, 393–408.CrossRefGoogle ScholarPubMed
Habbema, J. F. D., Lubbe, J. Th. N., van, Agt H. M. E. et al. , Kosten en effecten van bevolkingsonderzoek op baarmoederhalskanker. Rotterdam: Enstituut Maatschappelijke Gezondheidszorg, Erasmus Universiteit, 1988.Google Scholar
Keeler, E., & Cretin, S.Discounting of life savings and other non-monetary effects. Management Science, 1983, 29, 300–06.CrossRefGoogle Scholar
Studiegroep Discontering. De rol van de disconteringsvoet in het beleid. Den Haag: Ministerie van Financiën, 1985.Google Scholar
Van, der Maas J. p., van, Ineveld B. M., van, Oortmarssen J. G., et al. De kosten en effecten van bevolkingsonderzoek op borstkanker. Interimrapport 1987. Rotterdam. lnstituut Maatschappelijke Gezondheidszorg, Erasmus Universiteit Rotterdam, 1987.Google Scholar
Pauker, S. G., & Kassirer, J. P.Decision analysis. New England Journal of Medicine, 1987, 316, 250–58.Google Scholar
Schieber, G. J.Financing and delivering health care: a comparative analysis of OECD countries. OECD social policy studies no. 4. Paris: Organization for Economic Co-operation and Development, 1987.Google Scholar
Van Doorslaer, E. K. A., Rutten, F. E H., & Haan, G. H. M. G. Economische evaluatie van preventieve gezondheidszorg: Is een “ons” preventie een “pond” therapie waard? In Lapré, R. M., Rutten, F. F. H., & Hagen, J. H. (eds.), De economie van de preventieve gezondheidszorg. Lochem: De Tijdstroom, 1988.Google Scholar
Vermeer, F., Simoons, M. L., de, Swaan C. et al. Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase. British Heart Journal, 1988, 59, 527–34.CrossRefGoogle ScholarPubMed
Weinstein, M. Economic techniques for technology assessment. In Rutten, F. F. H. & Reiser, S. J. (eds.). The economics of medical technology. Heidelberg: Springer, 1988, 44–53.Google Scholar
Weinstein, M. C., & Stason, W. B.Foundations of cost-effectiveness analysis for health and medical practices. New England Journal of Medicine, 1977, 296, 716–21.Google Scholar